Major expansion boosts Rockford's pharmaceutical manufacturing footprint
PCI Pharma Services is expanding operations in Rockford with the opening of three new facilities on Sept. 22, a move the company says will add roughly 650 jobs to the region and further develop the city’s role in advanced drug-delivery manufacturing. The facilities are sited near Linden and Alpine roads and will be formally commissioned with public ceremonies and tours beginning at 1 p.m.
The Rockford campus is already the company’s largest worldwide, and this growth will enlarge that footprint. The site focuses on clinical-stage and commercial packaging for complex pharmaceutical and medical-device combination products — including final assembly and packaging for autoinjectors, prefilled syringes and injector pens. Company representatives invited local and regional dignitaries and members of the media to attend the Sept. 22 event.
- New hires: About 650 additional positions spanning production and technical roles.
- Types of roles: Line operators, project managers, technical engineering and quality positions tied to drug-device products.
- Campus scale: The Rockford complex already comprises eight facilities and employs more than 3,000 people.
The expansion is part of a broader investment exceeding $1 billion across PCI’s U.S. and European operations, the company said in its announcement. According to that statement, the funding is intended to strengthen the company’s ability to support clients from early clinical trials through commercial manufacturing and global launches.
| Item | Figure |
|---|---|
| New jobs in Rockford | ~650 |
| Existing Rockford employees | 3,000+ |
| Total campus facilities | 8 |
| Company-wide investment | $1 billion+ |
Local economic and workforce implications are significant. Adding hundreds of positions for production, engineering and quality assurance would broaden hiring opportunities for residents across skill levels, from entry-level line operators to technically trained engineers and project managers. The announcement indicates roles will support drug-device combination products — a specialized segment of pharmaceutical manufacturing that can command higher wages and demand specific training.
For Rockford, where large manufacturing employers anchor the local economy, the expansion cements the city’s position as a hub for advanced pharmaceutical packaging and assembly. The added capacity may also draw related suppliers and service providers to the area, supporting secondary job growth. Media were invited to RSVP through pci.com for coverage of the commissioning ceremonies and facility tours.
Officials and workforce partners will likely face near-term pressure to coordinate recruitment, training and onboarding for the incoming positions. While the company did not provide a detailed hiring timeline beyond the announcement, the scope of the jobs listed suggests a phased approach across production shifts and specialized teams. Local educational institutions, workforce boards and vocational programs may find new opportunities to partner with PCI for curricula or training pipelines aligned with the company’s technical needs.
PCI describes itself as a contract development and manufacturing organization serving pharmaceutical and medical device firms. The Rockford expansion further increases capacity for advanced drug delivery systems and related packaging operations, according to the announcement. As the campus grows, so will Rockford’s visibility in the supply chains that bring increasingly complex drug-delivery products to market.
Residents interested in employment or learning more about the opening event were directed to the company’s website for RSVP details. The Sept. 22 commissioning represents a milestone for both PCI and Rockford as the city seeks to expand high-quality manufacturing employment and attract investment in skilled production sectors.
